PharmacyChecker Blog

Helping Americans Get The Truth About Prescription Drug Savings
Published by:

Healthcare Law Provisions Meant to Simplify Medicare Drug Plan Selection Process May Add Confusion

About three million seniors enrolled in Medicare may have to switch their prescription drug benefit plan next year, says TheHill.com. The changes are due to provisions of the healthcare law that seek to make it easier for people to choose Medicare Part D plans. However, the process of change itself may be messy for many.  The purpose is to create fewer plans per region by requiring that plan sponsors drop plans that offer no “meaningful differences” from other plans offered by those same sponsors. Prior to the passage of healthcare legislation, many experts had criticized the number of available plans as too complicated and called for such streamlining.

But critics point out that these changes break the Obama administration’s promise that consumers can keep their current plans. The final changes are yet to be determined, but they are expected to make things easier for first time enrollees and more difficult for customers already participating in the plans.

Unfortunately, some Medicare enrollees discover that their plans do not cover the drugs they need, forcing them to pay out-of-pocket for such products. Comparing prices online at PharmacyChecker.com can help.

To read and write reviews of Medicare drug plans, see our sister site, MedicareDrugPlans.com.

Share
Tagged with: , , , ,

New AARP Report Shows Dramatic Brand Name Drug Price Hikes

AARP, the leading advocacy group for America’s seniors, released a new study confirming that brand name drug prices were way up – 8.3 % higher on average – in 2009. These large increases occurred during a year  when the consumer price index was actually down by .4% . The report also finds that over the past five years, brand-name drug costs have increased by 41.5%, during which inflation only rose by 13%. Noteworthy in this report is that its authors, responding to pharmaceutical industry critics who contested that prior AARP reports only looked at manufacturer prices, derived the current findings by calculating the average retail prices of over 200 popular brand name drugs.

(more…)

Share
Tagged with: , , , ,